Derived from a protective protein sequence known as Body Protection Compound (BPC), BPC-157 is a synthetic peptide consisting of 15 amino acids that has attracted significant scientific interest due to its broad range of research applications
The reason often comes down to a concept we prioritize at Cymbiotika: bioavailability
subcutaneous produces reliable systemic absorption Requires greater technique and carries a marginally higher risk of injection site reaction Who injection is best suited for: Tendon, ligament, or muscle injuries Post-surgical tissue recovery Bone healing support Systemic anti-inflammatory goals Any indication where the target tissue is not the GI tract Practical considerations: Requires comfort with self-injection or clinical administration Sterile preparation is non-negotiable contaminated peptide solutions carry real infection risk Quality of the compound matters enormously
J.KupryszewskiG.WitczukB.WiniewskiK
Renna M, Jimenez-Sanchez M, Sarkar S, Rubinsztein DC (2010) Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases
CagriSema pairs cagrilintide with semaglutide (a GLP-1-only drug)